235 related articles for article (PubMed ID: 15799325)
1. [Histopathological study on the process of joint destruction in rheumatoid arthritis].
Itoh Y; Takahashi Y; Sawai T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():96-9. PubMed ID: 15799325
[No Abstract] [Full Text] [Related]
2. [Osteoclastic bone resorption in joint destruction of rheumatoid arthritis].
Kawaguchi H
Ryumachi; 2000 Feb; 40(1):32-8. PubMed ID: 10783664
[No Abstract] [Full Text] [Related]
3. [Histopathological features of joint destruction in rheumatoid arthritis (RA)].
Uzuki M; Sawai T; Sasaki Y
Clin Calcium; 2007 Apr; 17(4):474-83. PubMed ID: 17404475
[TBL] [Abstract][Full Text] [Related]
4. [Role of osteoclasts in bone destruction in rheumatoid arthritis].
Suzuki Y
Nihon Rinsho Meneki Gakkai Kaishi; 2001 Jun; 24(3):87-97. PubMed ID: 16578961
[No Abstract] [Full Text] [Related]
5. A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL.
Hui W; Cawston TE; Richards CD; Rowan AD
Arthritis Res Ther; 2005; 7(1):R57-64. PubMed ID: 15642143
[TBL] [Abstract][Full Text] [Related]
6. [Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis].
Hikita A; Tanaka S
Nihon Rinsho; 2005 Jan; 63 Suppl 1():84-6. PubMed ID: 15799323
[No Abstract] [Full Text] [Related]
7. [Mechanism of the bone destruction in rheumatoid arthritis].
Nakamura M; Tanaka S
Nihon Rinsho; 2005 Sep; 63(9):1571-3. PubMed ID: 16164213
[TBL] [Abstract][Full Text] [Related]
8. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
[TBL] [Abstract][Full Text] [Related]
9. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of joint destruction in rheumatoid arthritis.
Cunnane G; Hummel KM; Muller-Ladner U; Gay RE; Gay S
Arch Immunol Ther Exp (Warsz); 1998; 46(1):1-7. PubMed ID: 9510939
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt.
Hashiramoto A; Sakai C; Yoshida K; Tsumiyama K; Miura Y; Shiozawa K; Nose M; Komai K; Shiozawa S
Arthritis Rheum; 2007 Jul; 56(7):2170-9. PubMed ID: 17599743
[TBL] [Abstract][Full Text] [Related]
12. [Possible roles of TNF family cytokines in bone destruction of rheumatoid arthritis].
Udagawa N; Kotake S; Kamatani N; Takahashi N; Suda T
Ryumachi; 2002 Feb; 42(1):3-12. PubMed ID: 11925905
[No Abstract] [Full Text] [Related]
13. [Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis].
Yoshihara Y; Yamada H
Clin Calcium; 2007 Apr; 17(4):500-8. PubMed ID: 17404478
[TBL] [Abstract][Full Text] [Related]
14. [The disease picture in rheumatoid arthritis as a result of different pathomechanisms].
Fassbender HG
Z Rheumatol; 1985; 44(1):33-40. PubMed ID: 3157277
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of an equine model of synovitis-induced arthritis.
Todhunter PG; Kincaid SA; Todhunter RJ; Kammermann JR; Johnstone B; Baird AN; Hanson RR; Wright JM; Lin HC; Purohit RC
Am J Vet Res; 1996 Jul; 57(7):1080-93. PubMed ID: 8807026
[TBL] [Abstract][Full Text] [Related]
16. Osteoclasts, pro-inflammatory cytokines, RANK-L and bone remodeling in rheumatoid arthritis.
Kaplan C; Finnegan A
Front Biosci; 2003 May; 8():d1018-29. PubMed ID: 12700082
[TBL] [Abstract][Full Text] [Related]
17. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
18. [Joint destruction and matrix metalloproteinases--regulation by pharmacologic inhibitors and growth factors].
Matsumoto T
Clin Calcium; 2004 Jul; 14(7):108-13. PubMed ID: 15577086
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand expression in fibroblast-like synoviocytes from rheumatoid arthritis and osteoarthritis patients.
Harashima SI; Tsukamoto H; Horiuchi T
Rheumatology (Oxford); 2004 Mar; 43(3):396-7; author reply 397. PubMed ID: 14963213
[No Abstract] [Full Text] [Related]
20. Morphological characterization of receptor activator of NFkappaB ligand (RANKL) and IL-1beta expression in rodent collagen-induced arthritis.
Weiss RJ; Erlandsson Harris H; Wick MC; Wretenberg P; Stark A; Palmblad K
Scand J Immunol; 2005 Jul; 62(1):55-62. PubMed ID: 16092922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
